Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

NPJ vaccines·2026
Same author

Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles.

Analytical chemistry·2025
Same author

Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia.

Research and practice in thrombosis and haemostasis·2025
Same author

A Robust Human Liver Organoid Model of Hepatitis B Virus Infection.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale.

Biotechnology and bioengineering·2025
Same author

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.

EBioMedicine·2023
Same journal

Evidence that ginger (Zingiber officinale) does not prevent motion sickness in adults.

Journal of travel medicine·2026
Same journal

Assessment of the healthcare burden of dengue disease in England: a retrospective analysis (2010-2023).

Journal of travel medicine·2026
Same journal

Dengue without international travel: Europe at the interface of seasonality, vectors, and preparedness.

Journal of travel medicine·2026
Same journal

The PHEIC Threshold: What Ebola Has That Hantavirus Does Not.

Journal of travel medicine·2026
Same journal

Counting everyone onboard is not enough: modelling lessons from the MV Hondius Andes virus outbreak.

Journal of travel medicine·2026
Same journal

What leads to a public health emergency of international concern? A comparison of the 2026 Ebola and hantavirus outbreaks.

Journal of travel medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Crohn's disease or tuberculosis?

Kiley W J Loh1, Raouf Bassily, Joseph Torresi

  • 1Department of Medicine, The Northern Hospital, Epping, Victoria, Australia. kiley_loh@yahoo.com

Journal of Travel Medicine
|May 5, 2011
PubMed
Summary
This summary is machine-generated.

Diagnosing intestinal tuberculosis in migrants is crucial, especially when symptoms mimic Crohn's disease. Early differentiation ensures appropriate treatment and prevents complications like TB dissemination, particularly with increasing migration from TB-endemic regions.

Related Experiment Videos

Last Updated: Jun 2, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Public Health

Background:

  • Crohn's disease and intestinal tuberculosis (TB) present similar gastrointestinal symptoms.
  • Accurate differentiation is essential for effective patient management.
  • Migration patterns necessitate awareness of endemic infectious diseases.

Observation:

  • A Nepali-born migrant initially evaluated for Crohn's disease was ultimately diagnosed with intestinal TB.
  • The diagnostic challenge highlights the overlap in clinical presentations.

Findings:

  • Intestinal tuberculosis can mimic Crohn's disease, posing a diagnostic challenge.
  • Delayed diagnosis of intestinal TB can lead to severe complications.

Implications:

  • Clinicians must consider intestinal TB in migrants from endemic areas, even with initial suspicion of Crohn's disease.
  • Misdiagnosis can lead to inappropriate immunosuppressive therapy for Crohn's, potentially causing TB dissemination.
  • Enhanced diagnostic strategies are needed to distinguish between these conditions in at-risk populations.